Legend Biotech (LEGN) Dividends Paid - Common Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) Dividends Paid - Common Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -10.39% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -95.23% |
| Jun 30, 2025 | 74.85% |
| Mar 31, 2025 | -50.79% |
| Sep 30, 2024 | 195.66% |
| Jun 30, 2024 | -221.49% |
| Mar 31, 2024 | 35.99% |
| Sep 30, 2023 | -162.30% |
| Jun 30, 2023 | 28,702.16% |
| Mar 31, 2023 | 74.72% |
| Sep 30, 2022 | 388.87% |
| Jun 30, 2022 | -97.38% |
| Mar 31, 2022 | -8.37% |
| Dec 31, 2021 | 51.19% |
| Sep 30, 2021 | -32.63% |
| Jun 30, 2021 | -80.71% |
| Mar 31, 2021 | 144.26% |
| Dec 31, 2020 | 446.63% |
| Sep 30, 2020 | -411.53% |
| Jun 30, 2020 | 943.43% |